3 news items
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
NTLA
9 May 24
" or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
NTLA
2 Apr 24
New York--News Direct--Kuehn Law, PLLC, a shareholder litigation law firm
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
NTLA
18 Mar 24
" or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include
- Prev
- 1
- Next